Get the up-to-date Treatment of HeartMate II Short-to-Shield Patients With an 2024 now

Get Form
Treatment of HeartMate II Short-to-Shield Patients With an Preview on Page 1.

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

How to modify Treatment of HeartMate II Short-to-Shield Patients With an in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Adjusting documents with our extensive and intuitive PDF editor is straightforward. Follow the instructions below to fill out Treatment of HeartMate II Short-to-Shield Patients With an online quickly and easily:

  1. Sign in to your account. Sign up with your email and password or create a free account to try the service prior to choosing the subscription.
  2. Upload a document. Drag and drop the file from your device or import it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit Treatment of HeartMate II Short-to-Shield Patients With an. Easily add and highlight text, insert pictures, checkmarks, and icons, drop new fillable areas, and rearrange or remove pages from your paperwork.
  4. Get the Treatment of HeartMate II Short-to-Shield Patients With an accomplished. Download your updated document, export it to the cloud, print it from the editor, or share it with other participants using a Shareable link or as an email attachment.

Benefit from DocHub, the most straightforward editor to quickly handle your documentation online!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The short-to-shield (STS) phenomenon is a specific type of LVAD driveline dysfunction observed in Heartmate II patients due to damage to driveline wiring insulation that results in pump stoppage when connected to a grounded power base. There is a risk of complete power failure with additional wire damage.
Most often when a LVAD is turned off the patient dies within minutes. However, if there is intrinsic heart function the patient may live for several days.
At age 84, Gayle, holds the honor of living on a left ventricular assist device (LVAD) for 10 years. Those odds dont always work that kind of wonder for many only a few patients in the U.S. have achieved that milestone.
The short-to-shield (STS) phenomenon is an uncommon drive-line (DL) dysfunction resulted from broken insulator causing an underlying wire to contact a metallic shield in a DL. This leads to a short circuit and a pump stoppage.
One cause of driveline failure in the HeartMate II is damage to the wiring insulation of the percutaneous lead resulting in an electrical short to ground, referred to as a short to shield (STS). The percutaneous lead has six electrical wires attached to six motor stators to power a three-phase pump.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

The short-to-shield (STS) phenomenon is an uncommon drive-line (DL) dysfunction resulted from broken insulator causing an underlying wire to contact a metallic shield in a DL. This leads to a short circuit and a pump stoppage.
Bleeding complications. Bleeding is the most common adverse event after LVAD implantation. Patients with LVADs require antiplatelet and anticoagulant therapy, which predisposes them to bleeding complications.
Low flow alarms (LFAs) in LVAD can occur due to a multitude of conditions. The differential diagnosis includes: hypovolemia, tamponade, right ventricular failure, hypertension, arrythmias, inflow cannula malposition, outflow cannula obstruction, and pre-pump inflow cannula thrombosis.

Related links